Literature DB >> 17618625

Endobrevin/VAMP8 mediates exocytotic release of hexosaminidase from rat basophilic leukaemia cells.

Undine Lippert1, David M Ferrari, Reinhard Jahn.   

Abstract

Mast cells are important players in innate immunity and mediate allergic responses. Upon stimulation, they release biologically active mediators including histamine, cytokines and lysosomal hydrolases. We used permeabilized rat basophilic leukaemia cells as model to identify R-SNAREs (soluble NSF (N-ethylmaleimide-sensitive fusion protein)) mediating exocytosis of hexosaminidase from mast cells. Of a complete set of recombinant mammalian R-SNAREs, only vesicle associated membrane protein (VAMP8)/endobrevin consistently blocked hexosaminidase release, which was also insensitive to treatment with clostridial neurotoxins. Thus, VAMP8, which also mediates fusion of late endosomes and lysosomes, plays a major role in hexosaminidase release, strengthening the view that mast cell granules share properties of both secretory granules and lysosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618625     DOI: 10.1016/j.febslet.2007.06.057

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Vesicle-associated membrane protein 8 (VAMP8) is a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) selectively required for sequential granule-to-granule fusion.

Authors:  Natasha Behrendorff; Subhankar Dolai; Wanjin Hong; Herbert Y Gaisano; Peter Thorn
Journal:  J Biol Chem       Date:  2011-07-06       Impact factor: 5.157

Review 2.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes.

Authors:  Yoosoo Yang; Jung-Mi Oh; Paul Heo; Jae Yoon Shin; Byoungjae Kong; Jonghyeok Shin; Ji-Chun Lee; Jeong Su Oh; Kye Won Park; Choong Hwan Lee; Yeon-Kyun Shin; Dae-Hyuk Kweon
Journal:  Biochem J       Date:  2013-03-15       Impact factor: 3.857

4.  Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation.

Authors:  Orietta D'Orlando; Fang Zhao; Brigitte Kasper; Zane Orinska; Jürgen Müller; Irm Hermans-Borgmeyer; Gillian M Griffiths; Udo Zur Stadt; Silvia Bulfone-Paus
Journal:  Eur J Immunol       Date:  2012-12-12       Impact factor: 5.532

5.  A role for VAMP8/endobrevin in surface deployment of the water channel aquaporin 2.

Authors:  Cheng-Chun Wang; Chee Peng Ng; Hong Shi; Hwee Chien Liew; Ke Guo; Qi Zeng; Wanjin Hong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

6.  Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Traffic       Date:  2014-03-07       Impact factor: 6.215

7.  The SNARE Machinery in Mast Cell Secretion.

Authors:  Axel Lorentz; Anja Baumann; Joana Vitte; Ulrich Blank
Journal:  Front Immunol       Date:  2012-06-05       Impact factor: 7.561

8.  Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase.

Authors:  Simon Hör; Tamar Ziv; Arie Admon; Paul J Lehner
Journal:  Mol Cell Proteomics       Date:  2009-05-20       Impact factor: 5.911

9.  Thymic alterations in mice deficient for the SNARE protein VAMP8/endobrevin.

Authors:  Namita Kanwar; Afshin Fayyazi; Bianca Backofen; Mirko Nitsche; Ralf Dressel; Gabriele Fischer von Mollard
Journal:  Cell Tissue Res       Date:  2008-10-16       Impact factor: 5.249

10.  Evidence for lysosomal exocytosis and release of aggrecan-degrading hydrolases from hypertrophic chondrocytes, in vitro and in vivo.

Authors:  Edward R Bastow; Karena Last; Sue Golub; Jennifer L Stow; Amanda C Stanley; Amanda J Fosang
Journal:  Biol Open       Date:  2012-02-10       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.